Halozyme Therapeutics Competitors and Similar CompaniesClear all

Blueprint Medicines's competitors and similar companies include Agenus.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
Agenus
Agenus
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
Founding Date
Founding Date
2011
Founding Date
1994
Type
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Amsterdam, NL
Lugano, CH
Zug, CH
Locations
Lexington, US HQ
Cambridge, GB
Emeryville, US
Berkeley, US
Vacaville, US
Employees
Employees
6552% increase
Employees
38927% decrease
Valuation ($)
Valuation ($)
5.3 b
Valuation ($)
96.2 m

Financial

Revenue (est.)
Revenue (est.)
$508.8m (FY, 2024)
Revenue (est.)
$103.5m (FY, 2024)
Cost of goods
Cost of goods
$20.2m (FY, 2024)
Cost of goods
$486k (FY, 2024)
Gross profit
Gross profit
$488.7m (FY, 2024)
Gross profit
$103m (FY, 2024)
Net income
Net income
($67.1m) (FY, 2024)
Net income
($232.3m) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 1.7b
Total funding raised
$ 171.1m
For sources of this data, please see the company profile

View Company Profiles

Agenus
HQ
Lexington, US
Employees
389↓ 27% decrease

Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.

View company